Intellectual property, patent litigation, patent prosecution, patent post-grant, IP transactions, life sciences, technology and innovation.
Gina Shishima is the US Head of Intellectual Property. She focuses on patent prosecution, due diligence, post-grant proceedings, and patent litigation matters for biotechnology, medical devices, chemical, and pharmaceutical companies, as well as universities and hospitals. Her significant experience includes patent portfolio management and patent counseling, as well as involvement in inter partes reviews (IPR), reexaminations, interferences, and European oppositions. Other experience includes a wide variety of involvement in patent litigation matters and licensing issues. In addition, Gina has experience in patentability opinions, freedom to operate evaluations, intellectual property due diligence, and competitive technology assessments.
American Intellectual Property Law Association, National Asian Pacific American Bar Association (formerly Board of Governors and co-chair Women's Leadership Network).
JD, University of California, Berkeley, School of Law (1998); PhD, Molecular Biology, Princeton University (1995); AB, Biochemistry, Columbia University (1989).